Sex
|
Female |
11 (73) |
4 (57) |
3 (60) |
Male |
4 (27) |
3 (43) |
2 (40) |
Location
|
Rural |
6 (40) |
6 (86) |
1 (20) |
Urban |
9 (60) |
1 (14) |
4 (80) |
Age, years
|
30–39 |
1 (7) |
1 (14) |
2 (40) |
40–49 |
1 (7) |
1 (14) |
1 (20) |
50–59 |
0 (0) |
0 (0) |
1 (20) |
60–69 |
8 (53) |
3 (43) |
1 (20) |
70–79 |
3 (20) |
1 (14) |
0 (0) |
80–89 |
2 (13) |
1 (14) |
0 (0) |
Years with hypothyroidism
|
≤5 |
2 (13) |
1 (14) |
3 (60) |
6–10 |
2 (13) |
4 (57) |
0 (0) |
11–20 |
5 (33) |
1 (14) |
2 (40) |
>20 |
6 (40) |
1 (14) |
0 (0) |
Other relevant health conditions
|
Coeliac disease |
0 (0) |
0 (0) |
0 (0) |
Pernicious anaemia |
2 (13) |
0 (0) |
0 (0) |
Gastrointestinal (gallstones/diverticulitis/irritable bowel syndrome/twisted bowel/constipation) |
4 (27) |
2 (29) |
2 (40) |
Type 2 diabetes |
3 (20) |
0 (0) |
0 (0) |
Other relevant medications
|
Calcium-containing drugs |
3 (20) |
0 (0) |
1 (20) |
Iron-containing drugs |
0 (0) |
1 (14) |
1 (20) |
Proton pump inhibitors |
3 (20) |
1 (14) |
1 (20) |
BMI
|
<20 |
1 (7) |
0 |
0 |
20–25 |
5 (33) |
1 (14) |
2 (40) |
26–30 |
5 (33) |
5 (71) |
2 (40) |
31–35 |
3 (20) |
1 (14) |
1 (20) |
36–40 |
1 (7) |
0 |
0 |
Daily levothyroxine dose, µg
|
25 |
1 (7) |
0 |
0 |
50 |
1 (7) |
0 |
0 |
75 |
2 (13) |
0 |
0 |
100 |
3 (20) |
2 (29) |
2 (40) |
125 |
3 (20) |
2 (29) |
3 (60) |
150 |
2 (13) |
0 |
0 |
175 |
0 (0) |
0 |
0 |
200 |
0 (0) |
0 |
0 |
225 |
0 (0) |
1 (14) |
0 |
100/125 alternate day dosing |
1 (7) |
1 (14) |
0 |
100/75 alternate day dosing |
0 (0) |
1 (14) |
0 |
100 Monday–Friday, 75 Saturday–Sunday |
2 (13) |
0 |
0 |